Back to search

Article

SARS-CoV-2 vaccine Alpha and Delta variant breakthrough infections are rare and mild, but happen relative early after vaccination

2021-12-24

Abstract excerpt

<h4>Introduction</h4> COVID-19 vaccines significantly reduce SARS-CoV-2 (SCoV2)-related hospitalization and mortality in randomized controlled clinical trials, as well as in real-world effectiveness against different circulating SCoV2-lineages. However, some vaccine recipients show breakthrough infection and it remains unknown, which host and viral factors contribute to this risk and how many resulted in severe ou...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
82809d6a-01bb-5fc2-95bf-f9af2d01fb00
DOI
10.1101/2021.12.23.21268324
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
SARS-CoV-2 vaccine Alpha and Delta variant breakthrough infections are rare and mild, but happen relative early after vaccinationDOI 10.1101/2021.12.23.21268324
Select a neighboring publication to make it the new centre.